Navigation Links
Indevus and FDA Agree on Path Forward for NEBIDO(R)
Date:9/26/2008

Existing European Data Will Be Used for NDA Resubmission

Planned For First Quarter 2009

LEXINGTON, Mass., Sept. 26 /PRNewswire-FirstCall/ -- Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV) announced today that it has reached agreement with the U.S. Food and Drug Administration (FDA) with regard to the additional data and risk management strategy that will lead to re-submission (complete response) of the New Drug Application (NDA) for NEBIDO(R) in the first quarter of calendar 2009. The re-submission database will include experience from over 14,000 injections in more than 2,600 patients, all of which come from existing clinical trials conducted in the U.S. and post-marketing studies that have been conducted in Europe. FDA stated that the number of patients and the number of injections of testosterone undecanoate from these studies appear to provide an adequate size database to determine the precise incidence of serious post-injection, oil-based reactions.

Indevus and FDA also agreed on an education plan to minimize the risks associated with the clinical use of testosterone undecanoate intramuscular injection, namely, to reduce the incidence and/or severity of the serious oil- based reactions. Further, Indevus and FDA agreed to obtain skin-testing data to characterize an allergic component to the drug or any of its excipients in certain patients. Indevus has also agreed to conduct a large, simple post- marketing study of the safety of NEBIDO in approximately 10,000 patients.

"We are very pleased that we can provide to FDA additional data from existing clinical trials to satisfy FDA's desire to understand the incidence of these rare oil-based reactions, without the need to conduct new clinica
'/>"/>

SOURCE Indevus Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Indevus Announces Private Placement of $105 Million of Non-Recourse Notes
2. Indevus Pharmaceuticals Announces Issuance of U.S. Patent for SANCTURA XR(TM)
3. Indevus Pharmaceuticals to Announce Third Quarter Fiscal 2008 Financial Results on August 5, 2008
4. Indevus Receives Approvable Letter from FDA for NEBIDO(R)
5. Indevus Announces Management Changes
6. Indevus Pharmaceuticals Scheduled to Present at Upcoming Investor Conferences
7. 125 Indevus Sales Representatives to Provide Community Service in New Orleans for Jericho Road Episcopal Housing Initiative
8. Indevus Pharmaceuticals to Present at Cowen and Company 28th Annual Health Care Conference
9. Indevus Comments on Bayer Healthcare Discontinuation of Viadur(R)
10. Indevus Receives Non-Approvable Letter From FDA for VALSTAR(TM)
11. Indevus Pharmaceuticals Announces Retirement of David B. Sharrock From Its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... ... ... The 2015 Market Research Report on the Global Propanol Industry is ... with a focus on the Chinese situation. Major companies included in the propanol market ... Royal Dutch Shell, LG Chem and Zhejiang Xinhua Chemical. , The report provides a ...
(Date:7/30/2015)...   Senomyx , Inc. (NASDAQ: SNMX ), ... discover, develop, and commercialize novel flavor ingredients for the ... results for the second quarter 2015. ... on track to achieve our commercial and financial goals," ... the Company. "Since our last quarterly earnings report, our ...
(Date:7/30/2015)... 2015  Discovery Laboratories, Inc. (Nasdaq: DSCO ... second $1.0M tranche under a previously awarded Phase ... at up to $3.0 million to support continued ... a potential medical countermeasure to mitigate acute and ... an initial $1.0 million under this grant in ...
(Date:7/29/2015)... July 30, 2015 Sanofi, ... publie ses résultats pour le premier semestre 2015. ... les résultats. Visionner l,interview vidéo et ... Au sommaire de l,interview :  ... Moteurs de croissance - Diabète ...
Breaking Biology Technology:Global Propanol Market Technical Data and Manufacturing Analysis 2020 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 2SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 4SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 5SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 6SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 7SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 8SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 9Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 2Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 3
... all the recent discussions, testimonies and other rhetoric given by ... as well as their lobbyists, we should be asking this ... with these various broadband products?" , ,What speed are you ... Are you getting a half T-1 for a full T-1 ...
... It may be a flat state, but at BIO 2006 ... will draw people from across the exhibition floor. The state's ... Forward Wisconsin previewed at its last downtown planning ... Alf, director of business development for Forward Wisconsin, is coordinating ...
... Corp. is opening a liason office with one or ... Hiroki Tanaka, vice president and general manager of NTT ... out opportunities for the company to expand further in ... during governor Jim Doyle's trade mission to Japan in ...
Cached Biology Technology:Are speedometers for high-speed Internet service a new must-have? 2Are speedometers for high-speed Internet service a new must-have? 3State pavilion goes for height, style at BIO expo 2
(Date:7/7/2015)... 7, 2015  Based on its recent analysis ... recognizes Credence ID, LLC with the 2015 Asia-Pacific ... the Year Award. Credence ID has developed a ... mission of offering enrollment and identification solutions to ... ID was formed by experts from the mobile ...
(Date:7/2/2015)... , June 25, 2015 ... addition of the "Next Generation Biometrics Market by ... 2020" report to their offering. The ... Billion by 2020, at a CAGR of 17.9% between ... the leading application for the market. Safran SA ...
(Date:6/30/2015)... Pa. , June 30, 2015 ... the company as CEO to help further develop Genisphere,s ... wealth of partnering experience, having spent much of the ... including Therakine, Amgen, Baxter Bioscience, and Johnson & Johnson. ... focus on Technology and Biotech Corporate Finance. He graduated ...
Breaking Biology News(10 mins):Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 2Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 3Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3
... operate on patients at most major hospitals, the next ... scenario -- the doctor. Feasibility studies conducted by ... without any human assistance -- can locate a man-made, ... device to the lesion and take multiple samples during ...
... and fruit taste delicious and are important sources of ... plants the cellulose in the cell wall. Even ... of the cell wall plays a crucial role in ... increasing the digestibility of animal feed, and of utilising ...
... To trap and hold tiny microparticles, engineers at Harvard have ... to confine particles stably for up to several minutes. ... Nano Letters , could one day lead to the ability ... chips. "We demonstrated the power of what we call ...
Cached Biology News:Next generation surgical robots: Where's the doctor? 2Next generation surgical robots: Where's the doctor? 3Cellulose: Hard to digest, but full of energy 2By 'putting a ring on it,' microparticles can be captured 2
NovaScreen offers cell biology, cell culture and molecular biology services for companies who lack a cell culture facility....
... Bank Service The Human Genetic Cell ... Virus (EBV) immortalisation of human peripheral blood ... lymphoblastoid cell lines (LCLs). These cell lines ... expandable source of genomic DNA and RNA. ...
... Application: The Panorama Mouse/Rat Tissue Extract ... protein expression in various tissue extracts. The ... is detected using a protein specific antibody. ... binding is visualized by a sensitive chemiluminescent ...
Glycerol-based mounting medium for immunofluorescence microscopy. Formulated to retard photobleaching of fluorochromes such as fluorescein and rhodamine. Product can also be used as a diluent for fl...
Biology Products: